SAVIENT PHARMACEUTICALS INC (SVNT) financial statements (2021 and earlier)

Company profile

Business Address ONE TOWER CENTER
EAST BRUNSWICK, NJ 08816
State of Incorp. DE
Fiscal Year End December 31
SIC 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments96
Cash and cash equivalents50
Short-term investments46
Receivables4
Inventory, net of allowances, customer advances and progress billings4
Inventory4
Prepaid expense and other current assets4
Total current assets:109
Noncurrent Assets
Property, plant and equipment2
Regulated entity, other noncurrent assets6
Restricted cash and investments3
Deferred costs5
Other undisclosed noncurrent assets(6)
Total noncurrent assets:10
TOTAL ASSETS:119
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities7
Accounts payable3
Interest and dividends payable3
Debt0
Deferred revenue and credits1
Other liabilities22
Other undisclosed current liabilities3
Total current liabilities:32
Noncurrent Liabilities
Long-term debt and lease obligation, including:223
Long-term debt, excluding current maturities223
Capital lease obligations0
Other undisclosed long-term debt and lease obligation(0)
Liabilities, other than long-term debt3
Other liabilities3
Total noncurrent liabilities:226
Total liabilities:258
Stockholders' equity
Stockholders' equity attributable to parent(138)
Common stock1
Additional paid in capital397
Accumulated other comprehensive loss(0)
Accumulated deficit(536)
Total stockholders' equity:(138)
Other undisclosed liabilities and equity(0)
TOTAL LIABILITIES AND EQUITY:119

Income statement (P&L) ($ in millions)

12/31/2012
Revenues
(Revenue, Net)
18
Cost of revenue
(Cost of Goods and Services Sold)
(22)
Gross profit:(4)
Operating expenses(137)
Other undisclosed operating income22
Operating loss:(119)
Nonoperating income0
Investment income, nonoperating0
Foreign currency transaction gain, before tax0
Other nonoperating income3
Interest and debt expense(2)
Other undisclosed income from continuing operations before equity method investments, income taxes3
Net loss available to common stockholders, diluted:(118)

Comprehensive Income ($ in millions)

12/31/2012
Net loss:(118)
Other comprehensive loss(0)
Comprehensive loss, net of tax, attributable to parent:(119)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: